why choose us

First received: April 04, 2023

Clinical Trial: Clinical Study of Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced Microsatellite-unstable Gastric Adenocarcinoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gastric Cancer

Study Type: OBSERVATIONAL


Official Title: Clinical Study of Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced Microsatellite-unstable Gastric Adenocarcinoma

Brief Summary: Our study is aim to evaluate the efficacy and safety of pabolizumab in neoadjuvant immunotherapy of locally advanced microsatellite-unstable gastric adenocarcinoma.

Read more